Skip to main content

Teri Lawver

Equibles does not estimate personal net worth.

Get an email with a short summary when Altimmune, Inc. publishes a filing, an earnings call transcript or a press release.

Get ALT alerts

About Teri Lawver

Teri Lawver is recorded as Board Member at Altimmune, Inc. (ALT) since February 24, 2025. Altimmune, Inc. reported in an 8-K filed February 27, 2025 that Teri Lawver was appointed Board of Directors. Altimmune, Inc. reported in an 8-K filed February 25, 2025 that Teri Lawver was appointed director of the Board, effective February 24, 2025. Altimmune, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Altimmune, Inc. includes Jerome Durso (CEO and Board Member), Vipin K. Garg (CEO), William Enright (CEO) and 7 others.

“The Company strengthened its Board of Directors with the appointments of pharmaceutical industry veterans Teri Lawver and Jerry Durso”
Altimmune, Inc. Form 8-K, filed February 27, 2025 · Read the filing
“On February 24, 2025, the Board of Directors (the "Board") of Altimmune, Inc. (the "Company"), upon the recommendation of the Nominating and Corporate Governance Committee of the Board, increased its size from eight to ten directors and appointed Teri Lawver and Jerome Durso as directors of the Board.”
Altimmune, Inc. Form 8-K, filed February 25, 2025 · Read the filing

Affiliation history

Company network

Current role

Biotechnology · Healthcare

Board Member

2025-02-24–present

Leadership on record at Altimmune, Inc.

Recent activity